Lunai Bioworks Inc. (LNAI)
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Lunai Bioworks Inc.
OTC:LNAIOTC (delisted from Nasdaq, Form 25 effective Nov 12, 2026)Healthcare · Biotechnology
+0.00%$0.1648
Prev close$0.1648+38.96%Open$0.2290-28.03%Now$0.1648
Mkt Cap$830K
EV-
Float4.88M
O/S5.03M
VOL1.27M sh
$ Vol$195K
RVOL0.86×
Inst Own3.8%
SI0.4%
Net Cash/Sh-
Dilution
MCap$830KFloat4.88MO/S5.03M
Dilution
Lunai Bioworks Inc. (LNAI) dilution facts from SEC filings
Snapshot as of Jun 30, 2026, built from 29 SEC filings.
- Shelf registration
- None on file in the filings reviewed
- At-the-market (ATM) program
- No active program in the filings reviewed
- Warrants outstanding
- 3 warrant series recorded as outstanding
Check another stock for dilution
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.